CJC-1295
GROWTH HORMONE RELEASING HORMONEQuick Specifications
| Vial Size | 10MG |
|---|---|
| BAC Water | 2ML |
| Amount Per Unit | 0.05MG PER UNIT |
| Recommended Dose | 1MG TO 2MG (10 TO 20 UNITS) |
| Frequency | 5 DAYS ON 2 OFF |
| Injection Type | SUBCUTANEOUS |
| Timing | Fasted Before Bed or Upon Waking |
Research Overview
INCREASES ENDOGENOUS IGF-1 - MINIMAL EFFECTS ON GHRELIN - THERMOGENIC - INCREASE MUSCLE MASS
How It Works
GHRH Receptor Agonism
CJC-1295 is a growth hormone releasing hormone (GHRH) analogue that binds and activates GHRH receptors in the pituitary gland, stimulating growth hormone synthesis and secretion. It works upstream from GHRPs like ipamorelin, targeting a different receptor.
Extended Half-Life (DAC Version)
CJC-1295 With DAC (Drug Affinity Complex) bonds to albumin in the bloodstream, extending its half-life from minutes to approximately 7–8 days. This allows once-weekly dosing while maintaining consistent GHRH receptor stimulation.
Synergistic GHRH + GHRP Action
When combined with ipamorelin or other GHRPs, CJC-1295 activates both the GHRH and ghrelin receptor pathways simultaneously, producing synergistic GH release substantially greater than either peptide alone — a key reason this combination is among the most studied.
Commonly Studied With
These peptides are frequently researched alongside CJC1295 - No DAC: 10mg due to complementary mechanisms:
CJC1295 - No DAC: 10mg information on this page is for research and educational purposes only. This content is not FDA-approved, does not constitute medical advice, and should not be used to guide personal health decisions. Consult a qualified healthcare professional before using any research compound.
Dose Calculator
Enter your target dose to calculate the volume to draw.
Recommended dose: 1MG TO 2MG (10 TO 20 UNITS)